Evaluation of the clinical efficacy and safety of Perindopril / Indapamide / Amlodipine fixed-dose combination in single-pill versus free dual therapy at the same dose as the single-pill combination in patients with uncontrolled essential hypertension

Trial Profile

Evaluation of the clinical efficacy and safety of Perindopril / Indapamide / Amlodipine fixed-dose combination in single-pill versus free dual therapy at the same dose as the single-pill combination in patients with uncontrolled essential hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Amlodipine/indapamide/perindopril (Primary) ; Amlodipine; Perindopril/indapamide
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Servier
  • Most Recent Events

    • 01 Jun 2017 Results published in the Cardiology and Therapy
    • 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 02 Apr 2014 Status changed from recruiting to completed reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top